NASD · Healthcare · Medical Devices · USA
Microbot Medical Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Microbot Medical is a medical device company developing robotic systems for minimally invasive endovascular surgery. The FDA-cleared LIBERTY Endovascular Robotic Surgical System is a fully disposable robot designed to maneuver guidewires and catheters within the body's vasculature for peripheral vascular and interventional procedures. The company also owns the NovaCross technology for intraluminal revascularization devices.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Microbot Medical Inc stock.
Undervalued: intrinsic value $0.93 per share, market price $0.69, margin of safety 25.7% (as of 2026-11-17).
A 0.6x revenue multiple, discounted for its losses, values the shares at $0.93; the price of $0.69 is 26% below that value.
2 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
6 more in this industry show a wider margin of safety.
MBOT is undervalued (as of the 2026-11-17 close). A 0.6x revenue multiple, discounted for its losses, values the shares at $0.93; the price of $0.69 is 26% below that value.
$0.93 per share (as of the 2026-11-17 close), against a market price of $0.69. That is a margin of safety of 25.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.